Skip to main content
Caplight Logo









Micreos Group

Micreos Group

Private
NetherlandsHealthcare & Life Scienceshttps://micreosgroup.com/

Last Round

Series D

Oct 25, 2022

Total Funding Raised

$61.65M

Company Overview

Micreos Group is a biotechnology company that develops targeted antibacterial products based on phage and endolysin technology to replace antibiotics in human health, food safety, and animal health applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Fashion & Beauty, D2C Brands, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Subscription SaaS

AI Layer

Non-AI

Keywords

endolysinphage therapyantimicrobialmicrobiomefood safetybiocontrolprecision medicineantibiotic resistanceskincaredermatologyphagebacteriophagetargeted therapybiotechpathogen control

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Micreos Group Comparables

Compare Micreos Group with similar companies based on industry and business-model similarity.

Micreos Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lysando AG
79%
BioNTech SE
71%
Intralytix, Inc.
70%

Micreos Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DOct 25, 2022
Series DSep 30, 2021
VC RoundMar 29, 2019
VC RoundFeb 18, 2016

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 25, 2022

    $25M round closed.

  • Mar 29, 2019

    $34M round raised.

Micreos Group Filings

Explore SEC and related filing metadata, where available.

Micreos Group filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Micreos Group's valuation, stock price, and market status.

Is Micreos Group a public or private company?

Micreos Group is a private company.

What is the current stock price of Micreos Group?

Micreos Group is a private company with no public stock price. No recent secondary market data is available.

How much is Micreos Group worth (valuation)?

Valuation information for Micreos Group is not publicly available.

Can I buy Micreos Group stock?

Micreos Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Micreos Group's last funding round?

Micreos Group's most recent funding round was Series D on October 25, 2022.

Who are the main investors in Micreos Group?

Investor information for Micreos Group is not publicly disclosed.

Will Micreos Group IPO soon?

No public IPO plans have been announced for Micreos Group.

How can I track Micreos Group secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Micreos Group's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNetherlands
Year Founded2005
Last FundingOct 25, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?